Effect of San-ao Decoction, a traditional Chinese prescription, on IL-4 treated normal human bronchial epithelium

Journal of Ethnopharmacology

Volumn 131, Issue 1, 2010, Pages 104-109

  Li, Yu ^a   Wang, Ming Yan ^a   Fan, Xin sheng ^a   Qi, Xu ^b   Chen, Yan ^a   Zhang, Huan ^a   Zhao, Qing chun ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Eotaxion 3; IL 4; Normal human bronchial epithelium; San ao Decoction

Indexed keywords

CAP BINDING PROTEIN; CHINESE DRUG; EOTAXIN 3; INTERLEUKIN 4; SAN AO; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CONTROLLED STUDY; EPHEDRA SINICA; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLYCYRRHIZA URALENSIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PRUNUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BRONCHI; CELL LINE; DRUGS, CHINESE HERBAL; HUMANS; INTERLEUKIN-4; RANDOM ALLOCATION; RECEPTORS, INTERLEUKIN-4; RESPIRATORY MUCOSA;

EID: 77955330681     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.06.006     Document Type: Article

References (30)

1. Ahdieh M., Vandenbos T., Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. American Journal of Physiology: Cell Physiology 2001, 281:C2029-C2038.
2. Banwell M.E., Tolley N.S., Williams T.J., Mitchell T.J. Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids. Cytokine 2002, 17:317-323.
3. Berkman N., Ohnona S., Chung F.K., Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24hours after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 2001, 24:682-687.
4. Cury-Boaventura M.F., Pompeia C., Curi R. Comparative toxicity of oleic acid and linoleic acid on Jurkat cells. Clinical Nutrition 2004, 23:721-732.
5. Forssmann U., Uguccioni M., Loetscher P., et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophile leukocytes. Journal of Experimental Medicine 1997, 185:2171-2176.
6. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Leder P., Luster A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Medicine 1996, 2:449-456.
7. Geng C.X., Zeng Z.C., Wang J.Y. Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis. World Journal of Gastroenterology 2003, 9:696-700.
8. Gessner A., Rollinghoff M. Biologic functions and signaling of the interleukin-4 receptor complexes. Immunobiology 2000, 201:285-307.
9. Hamilton L.M., Davies D.E., Wilson S.J., Kimber I., Dearman R.J., Holgate S.T. The bronchial epithelium in asthma-much more than a passive barrier. Monaldi Arch. Chest Dis. 2001, 56:48-54.
10. Holgate S.T. Epithelial damage and response. Clinical and Experimental Allergy 2000, 30(Suppl. 1):37-41.
11. Holgate S.T. Epithelium dysfunction in asthma. Journal of Allergy and Clinical Immunology 2007, 120:1233-1244.
12. Kitaura M., Suzuki N., Imai T., et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 1999, 274:27975-27980.
13. Kobayashi I., Yamamoto S., Nishi N., et al. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of IL-4 receptor and nuclear factor-kappaB. Annals of Allergy Asthma & Immunology 2004, 93:390-397.
14. Matsukura S., Stellato C., Georas S.N., et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. American Journal of Respiratory Cell and Molecular Biology 2001, 24:755-761.
15. McGahon A.J., Martin S.M., Bissonnette R.P., Mahboubi A., Shi Y., Mogil R.J., Nishioka W.K., Green D.R. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods in Cell Biology 1995, 46:153-185.
16. Montefort S., Roberts J.A., Beasley R., Holgate S.T., Roche W.R. The site of disruption of the bronchial epithelium in asthmatic and nonasthmatic subjects. Thorax 1992, 47:499-503.
17. Ribble D., Goldstein N.B., David A., Norris D.A., Shellman Y.G. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnology 2005, 5:12.
18. Rojas-Ramos E., Avalos A.F., Perez-Fernandez L., Cuevas-Schacht F., Valencia-Maqueda E., Teran L.E. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. European Respiratory Journal 2003, 22:310-316.
19. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Molecular Immunology 2002, 38:881-885.
20. Szliszka E., Bronikowska J., Majcher A., Miszkiewicz J., Krol W. Enhanced sensitivity of hormone-refractory prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. CEJ Urology 2009, 62:29-34.
21. Van den Toorn L.M., Prins J.B., de Jongste J.C., et al. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respiratory Medicine 2005, 99:779-787.
22. Venkayya R., Lam M., Willkom M., Grunig G., Corry D.B., Erle D.J. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. American Journal of Respiratory Cell and Molecular Biology 2002, 26:202-208.
23. Velden V.H., Versnel H.F. Bronchial epithelium: morphology, function and pathophysiology in asthma. European Cytokine Network 1998, 9:585-597.
24. Wills Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
25. Yamamoto S., Hamasaki Y., Ishii E., Ichimaru T., Miyazaki S. Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis. Annals of Allergy Asthma & Immunology 1997, 78:517-523.
26. Yamamoto S., Kobayashi I., Tsuji K., et al. Upregulation of IL-4 receptor by interferon-gamma; enhanced IL-4-induced eotaxin-3 production in airway epithelium. American Journal of Respiratory Cell and Molecular Biology 2004, 31:456-462.
27. Yin W., Jiang G., Takeyasu K., Zhou X. Stimulation of Na, KATPase by low potassium is dependent on transferrin. Journal of Membrane Biology 2003, 193:177-184.
28. Xie Y. The clinical application and experience of San-ao Decoction. Journal of Li Shen Zhen Medicine and Material Medica Research 2000, 11:548-1548.
29. Situ Z., Wu J. Cell Culture 2004, The Global Books Publishers, [M] Xi'an, p. 196.
30. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. Journal of Clinical Investigation 1999, 103:779-788.